1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > 2016 Germany Molecular Diagnostics and NAT Market: Supplier Shares and Sales Forecasts (DataPack)

This DataPack contains tables from VPGMarketResearch.com new report,

"2016 Germany Molecular Diagnostics and NAT Market: Supplier Shares and Sales Forecasts.”

For pricing information on DataPack sections or individual tables, please contact Customer Service.

Table Of Contents

2016 Germany Molecular Diagnostics and NAT Market: Supplier Shares and Sales Forecasts (DataPack)
German Molecular Diagnostics and NAT Market:
Sales Forecasts and Key Supplier Shares (DataPack)
Contents
This report provides:
° Five-year sales forecasts for the German Molecular Diagnostics market, including:
- Infectious Diseases
- Cancer
- Forensic Testing
- Genetic Diseases
- Paternity Testing/HLA Typing, and other applications.
° Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
° Sales and market shares for major suppliers of molecular diagnostics and NAT assays.


List of Tables
Table 1. Germany: Molecular Diagnostics Market by Major Application
Table 2. Germany: Infectious Disease Blood Screening NAT Reagent Market by Assay
Table 3. Germany: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
Table 4. Germany: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.